Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

This study has been completed.
Information provided by (Responsible Party):
Puma Biotechnology, Inc. Identifier:
First received: March 17, 2009
Last updated: May 10, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2009
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)